Viewing Study NCT01921751


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-01-12 @ 11:08 PM
Study NCT ID: NCT01921751
Status: TERMINATED
Last Update Posted: 2018-07-13
First Post: 2013-08-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Sponsor: Radiation Therapy Oncology Group
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-08
Start Date Type: None
Primary Completion Date: 2016-06
Primary Completion Date Type: ACTUAL
Completion Date: 2016-06
Completion Date Type: ACTUAL
First Submit Date: 2013-08-09
First Submit QC Date: None
Study First Post Date: 2013-08-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-10-06
Results First Submit QC Date: None
Results First Post Date: 2018-03-22
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-06-14
Last Update Post Date: 2018-07-13
Last Update Post Date Type: ACTUAL